Stephens analyst Scott Fidel lowered the firm’s price target on UnitedHealth (UNH) to $595 from $645 and keeps an Overweight rating on the shares after the company released its 2024 10-K that furnished additional financial disclosures around the debt stack and Optum external revenue contributions that the firm used to update its model. Following the annual report review, the firm maintains its 2025-2027 adjusted EPS estimates at $29.85, $34.00 and $38.40, respectively, but trimmed its price target to reflect a moderated target multiple, the analyst noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Home Depot upgraded, Flywire downgraded: Wall Street’s top analyst calls
- UnitedHealth downgraded to Hold from Buy at Erste Group
- Senator Grassley probing UnitedHealth billing practices, WSJ reports
- UnitedHealth drops 1% to $454.01 after WSJ report of Grassley probe
- UnitedHealth price target lowered to $560 from $610 at Argus